Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topical Intranasal Tranexamic Acid for Epistaxis in the Emergency Department

NCT02930941 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT02930941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02930941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topical Intranasal Tranexamic Acid for Epistaxis in the Emergency Department
Lead sponsor
University of California, Davis
Phase
Phase 4
Overall status
Terminated
Start date
February 29, 2016
Completion date
December 31, 2020
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epistaxis